TScan Therapeutics | IPO Presentation Deck | 43 slides · page 15 of 43
The chart demonstrates the specificity of the TargetScan platform by highlighting MAGE-A3 as the primary target with significantly higher fold-enrichment.
Pitch deck · product_demo · present_solution · balanced density
Slide locked Sign in to view
Slide schematic 4/4
chart 1/1 legend 1/1 paragraph 1/1 title 1/1
Components 4
scatter legend paragraph headline
Tools 0
∅
No tools
No canon tool match is anchored to this slide.
Metrics 0
∅
No metrics
No metric insight is anchored to this slide.
Frameworks 0
∅
No frameworks
No framework match is anchored to this slide.